| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.001 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |